Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Strack

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Journal of Lipid Research|October 30, 2012
Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosisAlison M Strack, Ester Carballo-Jane, Sheng-Ping Wang, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonistsChristina B Madsen-Duggan, John S Debenham, Thomas F Walsh, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2005
Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonistsJohn S Debenham, Christina B Madsen-Duggan, Thomas F Walsh, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityHarry R Chobanian, Yan Guo, Ping Liu, et al.
Journal of Medicinal Chemistry|March 27, 2009
1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesityPetr Vachal, Joan M Fletcher, Tung M Fong, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesityShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolismDonald J Marsh, Drew T Weingarth, Dawn E Novi, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2010
Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonistsLiangqin Guo, Zhixiong Ye, Jian Liu, et al.
Journal of Medicinal Chemistry|October 4, 2002
Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonistIyassu K Sebhat, William J Martin, Zhixiong Ye, et al.
The Journal of Experimental Medicine|August 17, 2005
11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in miceAnne Hermanowski-Vosatka, James M Balkovec, Kang Cheng, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Journal of Lipid Research|October 30, 2012
Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosisAlison M Strack, Ester Carballo-Jane, Sheng-Ping Wang, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonistsChristina B Madsen-Duggan, John S Debenham, Thomas F Walsh, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2005
Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonistsJohn S Debenham, Christina B Madsen-Duggan, Thomas F Walsh, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityHarry R Chobanian, Yan Guo, Ping Liu, et al.
Journal of Medicinal Chemistry|March 27, 2009
1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesityPetr Vachal, Joan M Fletcher, Tung M Fong, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2010
Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesityShuwen He, Zhixiong Ye, Peter H Dobbelaar, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolismDonald J Marsh, Drew T Weingarth, Dawn E Novi, et al.
Bioorganic & Medicinal Chemistry Letters|July 13, 2010
Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonistsLiangqin Guo, Zhixiong Ye, Jian Liu, et al.
Journal of Medicinal Chemistry|October 4, 2002
Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonistIyassu K Sebhat, William J Martin, Zhixiong Ye, et al.
The Journal of Experimental Medicine|August 17, 2005
11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in miceAnne Hermanowski-Vosatka, James M Balkovec, Kang Cheng, et al.
Pageof 14